|
Budget,
Health,
Research and Development,
Taxation and Finance
|
Access to treatments as it relates to the current regulatory and price negotiation processes to enhance timely access to all Health Canada approved MS disease-modifying therapies, with respect to the National Strategy for Drugs for Rare Diseases and national pharmacare.
|
|
Budget,
Employment and Training,
Health,
Pensions,
Taxation and Finance
|
Canada Pension Plan – Disability with respect to eligibility for persons with MS and other chronic and episodic disabilities
|
|
Budget,
Employment and Training,
Health,
Housing,
Pensions,
Taxation and Finance
|
Comprehensive disability income programs, with respect to persons with MS and other chronic and episodic disabilities
|
|
Budget,
Health,
Taxation and Finance
|
Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities
|
|
Budget,
Employment and Training,
Health,
Taxation and Finance
|
Employment Insurance sickness benefits, with respect to creation of flexible benefits for persons with MS and other episodic disabilities
|
|
Budget,
Employment and Training,
Health,
Housing,
Labour,
Pensions,
Research and Development,
Science and Technology,
Taxation and Finance,
Transportation
|
Federal Budget: Allocate funding for the Canada Disability Benefit, the Employment Insurance Sickness Benefit; health research; access to treatment and care; and other budgetary policy as it relates to MS.
|
|
Budget,
Health,
Housing,
Taxation and Finance
|
Home care, with respect to creation with provincial/ territorial governments programs relating to increased home care for persons with MS and other disabilities/ diseases and the support of caregivers
|
|
Budget,
Health,
Housing,
Taxation and Finance
|
Safe Long-Term Care Act with respect to persons affected by MS
|
|
Budget,
Health,
Research and Development,
Science and Technology,
Taxation and Finance
|
We ask the federal government to fund MS research in partnership with MS Canada, leveraging our connections and expertise to focus and further our understanding of MS, pursue leading-edge research on repair and regeneration, and explore prevention strategies, including targeting the Epstein-Barr virus (EBV).
|